View Entire Collection
By Clinical Topic
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
TUESDAY, Jan. 29 (HealthDay News) -- There does not appear to be an increased risk for complications in twin pregnancies with fibroid tumors compared with those without fibroid tumors, according to research published in the January issue of the American Journal of Obstetrics & Gynecology.
To estimate the risk of adverse obstetric outcomes associated with fibroid tumors in twin pregnancies, Molly J. Stout, M.D., of the Washington University School of Medicine in St. Louis, and colleagues conducted a retrospective cohort study involving 2,378 non-anomalous twin pregnancies with one or more fibroid tumors identified using ultrasound in the second trimester.
Overall, 2.3 percent of the pregnancies had fibroid tumors. Compared with twin pregnancies without fibroid tumors, the researchers found that the presence of fibroid tumors was not associated with increased odds of small-for-gestational-age growth, preterm delivery before 34 weeks of gestation, or other adverse outcomes.
"This investigation suggests that twin pregnancies with fibroid tumors are not at increased risk for adverse obstetric outcomes beyond that which exists for twin gestations without fibroid tumors. Specifically, adverse outcomes that previously were demonstrated in cohorts of singleton pregnancies with fibroid tumors are not seen in this cohort of twin pregnancies with fibroid tumors," the authors write. "Screening strategies that are already in place for women with twin pregnancies do not need to be altered based on the presence or absence of fibroid tumors."
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top